University of Pittsburgh

Structure-based drug design model that unifies de novo generation, docking, conformer generation, and pharmacophore conditioning via flow matching.

Vision-language foundation model pre-trained on screening mammogram-report pairs to improve data efficiency and robustness in breast cancer detection.